FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia

被引:0
|
作者
Dierlamm, J
Stul, M
Vranckx, H
Michaux, L
Weghuis, DEMO
Speleman, F
Selleslag, D
Kramer, MHH
Noens, LA
Cassiman, JJ
Van den Berghe, H
Hagemeijer, A
机构
[1] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[2] Clin Univ St Luc, Dept Hematol, B-1200 Brussels, Belgium
[3] Clin Genet Ctr, Utrecht, Netherlands
[4] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[5] Acad Hosp St Jan, Dept Hematol, Brugge, Belgium
[6] Hosp Eemland, Dept Internal Med, Amersfoort, Netherlands
[7] Univ Ghent, Dept Hematol, Ghent, Belgium
来源
GENES CHROMOSOMES & CANCER | 1998年 / 22卷 / 02期
关键词
D O I
10.1002/(SICI)1098-2264(199806)22:2<87::AID-GCC1>3.0.CO;2-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The inv(lb)(p13q22) masked by different translocations was detected by fluorescence in situ hybridization (FISH) and confirmed by molecular analysis in three adult patients presenting with acute myeloid leukemia (AML)-M2 (cases I and 3) and M4Eo (case 2). Cytogenetic analysis revealed 47,XX,t(9;16)(p23;p13),+22 (case I); 46,XX,t(1;16)(p32;p13) (case 2); and 46,XY,?del(16)(q22) (case 3). Using a panel of probes for chromosomes 1, 9, 16, and 20 as well as probes to detect inv(16), i.e., two cosmid contigs hybridizing proximally and distally to the 16p13 breakpoint, FISH demonstrated inv(16) involving the derivative 16 as well as reciprocal translocations between 16q22-qter and 9p24 (case I), 1p32 (case 2), and 20q13 (case 3). In addition, a small interstitial del(16)(p13p13) proximal to the MYH11 breakpoint was detected in case I. Reverse transcriptase-polymerase chain reaction (RT-PCR) and Southern blot analysis showed a CBFB-MYH11 fusion transcript and MYH11 rearrangement, respectively, in all three cases. We conclude that: I) inv(16) can be masked by other structural abnormalities involving chromosome 16; 2) some of the so-called variant translocations not explored at the molecular level may in fact represent a masked inv(16); and 3) FISH, RT-PCR, and Southern blot analyses are reliable tools to detect masked inv(16) and should be applied in all AML cases with structural changes of chromosome 16. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 50 条
  • [31] Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22)
    Kurata, Keiji
    Yamamoto, Katsuya
    Okazaki, Yoko
    Noguchi, Yoriko
    Matsui, Keiji
    Matsumoto, Hisayuki
    Inui, Yumiko
    Yakushijin, Kimikazu
    Ito, Mitsuhiro
    Nakamachi, Yuji
    Matsuoka, Hiroshi
    Saegusa, Jun
    Minami, Hironobu
    CANCER GENETICS, 2020, 241 : 72 - 76
  • [32] Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22):: Results from CALGB 8461
    Byrd, JC
    Ruppert, AS
    Mrózek, K
    Carroll, AJ
    Edwards, CG
    Arthur, DC
    Pettenatti, MJ
    Stamberg, J
    Koduru, PRK
    Moore, JO
    Mayer, RJ
    Davey, FR
    Larson, RA
    Bloomfield, CD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) : 1087 - 1094
  • [33] ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17) (Q22;Q21) DEVELOPING INV(16)(P13Q22) SECONDARY AML
    Akiki, J.
    Jeffries, S.
    Craddock, Ch.
    Griffiths, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 543 - 543
  • [34] A GENE FOR A MYOSIN PEPTIDE IS DISRUPTED BY THE INV(16)(P13Q22) IN ACUTE NONLYMPHOCYTIC LEUKEMIA M4EO
    VANDERREIJDEN, BA
    DAUWERSE, JG
    WESSELS, JW
    BEVERSTOCK, GC
    HAGEMEIJER, A
    VANOMMEN, GJB
    BREUNING, MH
    BLOOD, 1993, 82 (10) : 2948 - 2952
  • [35] The prognostic significance of 3′ CBFB deletions in inv(16)(p13q22)/t(16;16)(p13;q22)
    Huxley, E
    Griffiths, MJ
    Talley, P
    Whitworth, A
    Humphreys, M
    McKinley, M
    JOURNAL OF MEDICAL GENETICS, 2005, 42 : S81 - S81
  • [36] Acute myeloid leukemia with inv(16)(p13q22):: A fluorescent in situ hybridization study using a dual-color CBFB DNA probe.
    Aventín, A
    Vallespí, T
    Granada, I
    Duarte, J
    Carrio, A
    Sole, F
    Teixidó, M
    Martínez-Climent, J
    Nomdedéu, J
    Brunet, S
    Sierra, J
    BLOOD, 2001, 98 (11) : 580A - 580A
  • [37] Secondary chromosome aberrations in acute myeloid leukemia with t(8;21)(q22;q22), inv(16)(p13q22) or t(15;17)(q22;q21)
    Schoch, C
    Haase, D
    Haferlach, T
    Buchner, T
    Freund, M
    Link, H
    Loffler, H
    Fonatsch, C
    BLOOD, 1995, 86 (10) : 160 - 160
  • [38] DO LEUKEMIA PATIENTS WITH CHROMOSOME-16 INVERSION INV(16)(P13Q22) HAVE A RARE FRAGILE SITE AT 16Q22
    OHYASHIKI, K
    OHYASHIKI, JH
    TOYAMA, K
    ITO, H
    CANCER GENETICS AND CYTOGENETICS, 1988, 31 (01) : 31 - 34
  • [39] Detection of inv(16)(p13q22) by means of chromosome painting with a 16q-specific probe
    Li, M
    Xue, YQ
    Wu, YF
    Pan, JL
    CANCER GENETICS AND CYTOGENETICS, 2004, 150 (01) : 86 - 87
  • [40] ACUTE MYELOMONOCYTIC LEUKEMIA WITH MARROW EOSINOPHILIA (M4EO) AND INV(16)(P13Q22) IN A PATIENT WITH A HERITABLE FRAGILE SITE 16Q22
    ARTHUR, DC
    AASENG, SM
    BLOOMFIELD, CD
    CYTOGENETICS AND CELL GENETICS, 1985, 40 (1-4): : 572 - 572